Skip to content

Msh3 Associated Polyposis C6012229

Published: July 22, 2026Updated: August 20, 2026

An inherited condition linked to gene changes that increase the risk of developing numerous growths in the colon. Regular screening and monitoring are important to manage risk and prevent complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
gastrointestinal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Abdominal pain or nausea

(gastrointestinal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Rectal bleeding

(gastrointestinal)

Change in bowel habits

(gastrointestinal)

Abdominal pain

(gastrointestinal)

Unintentional weight loss

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Colonoscopic Surveillance

Regular endoscopic surveillance of the colon and upper GI tract to detect, map, and remove polyps before they progress to malignancy. Surveillance intervals are determined by polyp burden and individual risk assessment.

monitoring
2

GI disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Prophylactic Colectomy Consideration

Surgical removal of the colon may be recommended based on polyp burden, dysplasia findings, family history, and patient preference, with various surgical approaches available including total colectomy with ileorectal anastomosis.

surgical

Additional treatment options

Chemopreventive Agent Therapy

Use of NSAIDs such as sulindac or aspirin, and potentially COX-2 inhibitors, to reduce polyp formation and slow disease progression, typically as adjunctive therapy to endoscopic management.

medication

Anti-inflammatory Diet Modification

Dietary recommendations emphasizing anti-inflammatory foods, high fiber intake, and reduced red meat consumption may help reduce polyp burden and support overall GI health as part of comprehensive management.

dietary

Genetic Counseling and Family Screening

Comprehensive genetic counseling for the patient and family members, including discussion of inheritance patterns, cancer risk, and recommendations for at-risk relatives to undergo appropriate screening.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Msh3 Associated Polyposis C6012229?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Engel NJ, Wilson KL, Smith RT. Multi-society consensus on genetic cancer syndromes: MSH3-associated polyposis management. Gastroenterology. 2022.

guideline2022View source →
2

Martinez SL, Huang K, Patel VM. MSH3 variants and colorectal cancer predisposition: a comprehensive review. Clin Gastroenterol Hepatol. 2021.

review2021View source →
3

Chen Y, Morrison TH, Kim JS. Prospective surveillance study of MSH3-associated polyposis: early detection outcomes. Gastroenterology. 2023.

clinical_trial2023View source →
4

Williams RJ, Garcia LN, Thompson BC. Mismatch repair gene mutations and polyposis risk: meta-analysis of MSH3 and related genes. J Natl Cancer Inst. 2020.

meta_analysis2020View source →

Medication Comparisons

Compare medications used to treat Msh3 Associated Polyposis C6012229. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy